Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Maximal bronchodilation: a therapeutic target in COPD?

Agustí A, Dekhuijzen PR.

Lancet Respir Med. 2017 Jul;5(7):540-542. doi: 10.1016/S2213-2600(17)30211-4. No abstract available.


Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study.

van Helvoort HA, Willems LM, Dekhuijzen PR, van Hees HW, Heijdra YF.

NPJ Prim Care Respir Med. 2016 Oct 13;26:16054. doi: 10.1038/npjpcrm.2016.54.


Serial pulmonary function tests to diagnose COPD in chronic heart failure.

Minasian AG, van den Elshout FJ, Dekhuijzen PR, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Transl Respir Med. 2014 Dec;2(1):12. Epub 2014 Sep 25.


Retail sales of inhalation devices in European countries: so much for a global policy.

Lavorini F, Corrigan CJ, Barnes PJ, Dekhuijzen PR, Levy ML, Pedersen S, Roche N, Vincken W, Crompton GK; Aerosol Drug Management Improvement Team.

Respir Med. 2011 Jul;105(7):1099-103. doi: 10.1016/j.rmed.2011.03.012. Epub 2011 Apr 13.


The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD.

Vincken W, Dekhuijzen PR, Barnes P; ADMIT Group.

Prim Care Respir J. 2010 Mar;19(1):10-20. doi: 10.4104/pcrj.2009.00062. Review.


The ADMIT series--issues in inhalation therapy. 3) Mild persistent asthma: the case for inhaled corticosteroid therapy.

Corrigan CJ, Levy ML, Dekhuijzen PR, Crompton GK; ADMIT Working Group.

Prim Care Respir J. 2009 Sep;18(3):148-58. doi: 10.4104/pcrj.2009.00035. Review.

Supplemental Content

Loading ...
Support Center